|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Cytokinetics (NASDAQ: CYTK) through any online brokerage.
There are no as such competitors for Cytokinetics.
The latest price target for Cytokinetics (NASDAQ: CYTK) was reported by Wolfe Research on 2021-03-12. The analyst firm set a price target for 50.00 expecting CYTK to rise to within 12 months (a possible 102.43% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Cytokinetics (NASDAQ: CYTK) is $24.7 last updated Fri Apr 16 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Cytokinetics.
There is no upcoming split for Cytokinetics.